CN115052580A - 不含聚丙烯酸酯的化妆品制剂 - Google Patents
不含聚丙烯酸酯的化妆品制剂 Download PDFInfo
- Publication number
- CN115052580A CN115052580A CN202180012775.9A CN202180012775A CN115052580A CN 115052580 A CN115052580 A CN 115052580A CN 202180012775 A CN202180012775 A CN 202180012775A CN 115052580 A CN115052580 A CN 115052580A
- Authority
- CN
- China
- Prior art keywords
- preparation
- inci
- cosmetic
- formulation
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 17
- 239000000230 xanthan gum Substances 0.000 claims abstract description 16
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 16
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 16
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 15
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 5
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960001631 carbomer Drugs 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 43
- 238000009472 formulation Methods 0.000 claims description 38
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims description 23
- -1 2-ethylhexyloxy Chemical group 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 12
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 12
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000004904 UV filter Substances 0.000 claims description 9
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 5
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 3
- 229960005193 avobenzone Drugs 0.000 claims description 3
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 3
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- 229960001679 octinoxate Drugs 0.000 claims description 2
- 229960001173 oxybenzone Drugs 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 9
- 210000003491 skin Anatomy 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000000475 sunscreen effect Effects 0.000 description 8
- 239000000516 sunscreening agent Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- CECNDHFSHMZIOS-UHFFFAOYSA-N 5-(3-ethylhexan-3-ylamino)-4-hexyl-1H-triazin-6-one Chemical compound C(C)C(CCC)(NC=1C(NN=NC=1CCCCCC)=O)CC CECNDHFSHMZIOS-UHFFFAOYSA-N 0.000 description 3
- WVQROSPZAHXOLS-UHFFFAOYSA-N C(CCCCCCC)C(CCC)(NC=1C(NN=NC1)=O)CCCCCCCC Chemical compound C(CCCCCCC)C(CCC)(NC=1C(NN=NC1)=O)CCCCCCCC WVQROSPZAHXOLS-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 3
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 3
- XDXVJSNZLFEGAE-UHFFFAOYSA-N phenyl 3h-benzimidazole-5-sulfonate Chemical compound C=1C=C2N=CNC2=CC=1S(=O)(=O)OC1=CC=CC=C1 XDXVJSNZLFEGAE-UHFFFAOYSA-N 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- UADWUILHKRXHMM-UHFFFAOYSA-N 2-ethylhexyl benzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1 UADWUILHKRXHMM-UHFFFAOYSA-N 0.000 description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- VTQVLCXOOIFPBB-UHFFFAOYSA-N 4-ethyl-5-hexyl-1H-triazin-6-one Chemical compound C(C)C1=C(C(NN=N1)=O)CCCCCC VTQVLCXOOIFPBB-UHFFFAOYSA-N 0.000 description 2
- JYJAMZPYEGWUDM-UHFFFAOYSA-N 4-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCCCOC(=O)CCCCCCC JYJAMZPYEGWUDM-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 235000019501 Lemon oil Nutrition 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940050390 benzoate Drugs 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- 235000000484 citronellol Nutrition 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 229940100539 dibutyl adipate Drugs 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 2
- 239000001245 distarch phosphate Substances 0.000 description 2
- 235000013804 distarch phosphate Nutrition 0.000 description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 229960004881 homosalate Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010501 lemon oil Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- OSORMYZMWHVFOZ-UHFFFAOYSA-N phenethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCC1=CC=CC=C1 OSORMYZMWHVFOZ-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- 239000001244 (E)-1-(2,6,6-trimethyl-1-cyclohex-2-enyl)pent-1-en-3-one Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- VPKMGDRERYMTJX-XEHSLEBBSA-N (e)-1-[(1r)-2,6,6-trimethylcyclohex-2-en-1-yl]pent-1-en-3-one Chemical compound CCC(=O)\C=C\[C@H]1C(C)=CCCC1(C)C VPKMGDRERYMTJX-XEHSLEBBSA-N 0.000 description 1
- SBLKVIQSIHEQOF-OWOJBTEDSA-N (e)-octadec-9-enedioic acid Chemical compound OC(=O)CCCCCCC\C=C\CCCCCCCC(O)=O SBLKVIQSIHEQOF-OWOJBTEDSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- OLUJUQKZMDLFII-UHFFFAOYSA-N 1-phenyloct-1-en-3-ol Chemical compound CCCCCC(O)C=CC1=CC=CC=C1 OLUJUQKZMDLFII-UHFFFAOYSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- PPVDHXWQWABSBC-UHFFFAOYSA-N 2-(2,6-diethyl-4-hydroxy-3,5-dimethoxyphenyl)-2-hexyl-1,3-dioxane-4,6-dione Chemical compound CCC=1C(OC)=C(O)C(OC)=C(CC)C=1C1(CCCCCC)OC(=O)CC(=O)O1 PPVDHXWQWABSBC-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- HMKKIXGYKWDQSV-SDNWHVSQSA-N 2-Pentyl-3-phenyl-2-propenal Chemical compound CCCCC\C(C=O)=C/C1=CC=CC=C1 HMKKIXGYKWDQSV-SDNWHVSQSA-N 0.000 description 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- XIEWGQFCESQNBK-UHFFFAOYSA-N 2-hexanoyloxyethyl hexanoate Chemical compound CCCCCC(=O)OCCOC(=O)CCCCC XIEWGQFCESQNBK-UHFFFAOYSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- VGTGNWCVUAMGIZ-UHFFFAOYSA-N 2-methyl-2-phenylheptanal Chemical compound CCCCCC(C)(C=O)C1=CC=CC=C1 VGTGNWCVUAMGIZ-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- FGGSPCRNKDZEKY-UHFFFAOYSA-N 3-hexoxypentane-1,2,3-triol Chemical compound CCCCCCOC(O)(CC)C(O)CO FGGSPCRNKDZEKY-UHFFFAOYSA-N 0.000 description 1
- OXYRENDGHPGWKV-UHFFFAOYSA-N 3-methyl-5-phenylpentan-1-ol Chemical compound OCCC(C)CCC1=CC=CC=C1 OXYRENDGHPGWKV-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- NMUKKQFFBNEVJY-UHFFFAOYSA-K 4-O-bis[(4-oct-1-enoxy-4-oxobutanoyl)oxy]alumanyl 1-O-oct-1-enyl butanedioate Chemical compound [Al+3].CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O NMUKKQFFBNEVJY-UHFFFAOYSA-K 0.000 description 1
- 229940073735 4-hydroxy acetophenone Drugs 0.000 description 1
- YVSNOTITPICPTB-UHFFFAOYSA-N 4-methyl-2-(2-methylpropyl)oxan-4-ol Chemical compound CC(C)CC1CC(C)(O)CCO1 YVSNOTITPICPTB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- DKMROQRQHGEIOW-UHFFFAOYSA-N Diethyl succinate Chemical compound CCOC(=O)CCC(=O)OCC DKMROQRQHGEIOW-UHFFFAOYSA-N 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DUKPKQFHJQGTGU-UHFFFAOYSA-N Hexyl salicylic acid Chemical compound CCCCCCOC(=O)C1=CC=CC=C1O DUKPKQFHJQGTGU-UHFFFAOYSA-N 0.000 description 1
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 description 1
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 description 1
- 229920003102 Methocel™ E4M Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000426 Microplastic Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- 244000136948 Ocimum sanctum Species 0.000 description 1
- 235000004072 Ocimum sanctum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 230000037338 UVA radiation Effects 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 description 1
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 239000001518 benzyl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- NGHOLYJTSCBCGC-QXMHVHEDSA-N benzyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-QXMHVHEDSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- UFVWHIGSVGIZRQ-UHFFFAOYSA-N bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate Chemical compound C1=C(C(=O)OCC(CC)CCCC)C=CC2=CC(C(=O)OCC(CC)CCCC)=CC=C21 UFVWHIGSVGIZRQ-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- NGHOLYJTSCBCGC-UHFFFAOYSA-N cis-cinnamic acid benzyl ester Natural products C=1C=CC=CC=1C=CC(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- OQBIVESRYIWBPL-UHFFFAOYSA-N decan-4-yl octanoate Chemical compound CCCCCCCC(=O)OC(CCC)CCCCCC OQBIVESRYIWBPL-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940031765 diethylhexyl 2,6-naphthalate Drugs 0.000 description 1
- 229940116365 diethylhexyl syringylidenemalonate Drugs 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- VTTZNHFOGZURNY-UHFFFAOYSA-L disodium;2-oct-1-enylbutanedioate Chemical compound [Na+].[Na+].CCCCCCC=CC(C([O-])=O)CC([O-])=O VTTZNHFOGZURNY-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical class N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- MCVVUJPXSBQTRZ-ONEGZZNKSA-N methyl (e)-but-2-enoate Chemical compound COC(=O)\C=C\C MCVVUJPXSBQTRZ-ONEGZZNKSA-N 0.000 description 1
- JPTOCTSNXXKSSN-UHFFFAOYSA-N methylheptenone Chemical compound CCCC=CC(=O)CC JPTOCTSNXXKSSN-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229940098888 phenethyl benzoate Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229940046303 sodium cetostearyl sulfate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 description 1
- CLBALUNQCMWJSU-UHFFFAOYSA-L sodium;hexadecyl sulfate;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O CLBALUNQCMWJSU-UHFFFAOYSA-L 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/415—Aminophenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
含有a)羟丙基甲基纤维素和b)黄原胶的化妆品制剂,其中该制剂不含基于聚丙烯酸酯、卡波姆和聚乙烯吡咯烷酮的物质。
Description
技术领域
本发明涉及一种含有羟丙基甲基纤维素和黄原胶的化妆品制剂,其中该制剂不含聚丙烯酸酯、卡波姆和聚乙烯吡咯烷酮,本发明还涉及一种方法以及羟丙基甲基纤维素和黄原胶在不含聚丙烯酸酯的化妆品制剂中的用途。
背景技术
多年来,从优雅的白皙到“健康、运动的棕色皮肤”的趋势一直在持续。为了实现这一点,人们将其皮肤暴露在太阳辐射下,因为这会导致黑色素形成意义上的色素形成。然而,阳光中的紫外线辐射对皮肤也有破坏作用。除了急性损伤(晒伤)外,长期损伤(例如罹患皮肤癌的风险提高)会在UVB范围(波长:280-320nm)的光过度照射的情况下发生。UVB和UVA辐射(波长:320-400nm)过度作用还会导致结缔组织的弹性胶原纤维的弱化。这会导致许多光毒性和光过敏反应,并导致皮肤过早老化。
因此,为了保护皮肤,开发了一系列可用于化妆品制剂中的光防护过滤物质。在大多数工业化国家,这些UVA和UVB过滤剂以白名单的形式汇总于例如《化妆品条例》附件7。
然而,市售防晒剂的多样性不应掩盖这些现有技术制剂具有许多缺点的事实。
化妆品防晒剂的一种广泛使用形式围绕水上运动展开。防晒剂通常用于海滩度假、游泳、沐浴、冲浪、潜水、划船或其他人体皮肤与水发生接触的活动。
在所有这些活动中,为了充分防护紫外线,重要的是防晒剂具有一定的耐水性,并且不会在与水接触时立即从皮肤上洗掉。
为了提高化妆品防晒剂的耐水性,通常在这些制剂中加入所谓的成膜剂。成膜剂通常是基于聚丙烯酸酯或聚乙烯吡咯烷酮的聚合化合物,它们在皮肤上形成保护膜,旨在防止/延迟UV过滤剂从皮肤上洗掉。
聚丙烯酸酯也用作低分子量乳化剂的替代品。其中,乳化作用基于制剂中凝胶网络的形成,它使水环境中的油滴稳定并防止它们一起流动。
这种聚合物的使用越来越受到公众的批评。在公众讨论中,人们经常担心这种聚合物会对环境造成负担,类似于所谓的“微塑料”。在本公开的范围内,此类担忧是否合理和有科学依据的问题可以不予置评。然而,事实是,化妆品制造商和消费者对开发替代技术越来越感兴趣,以确保防晒剂和其他化妆品的耐水性和乳液稳定性。根据消费者的理解,制剂应“不含微塑料”。
发明内容
因此,本发明的目的是开发一种尽可能耐水的防晒剂,其中可以在很大程度上省去使用聚合物成膜剂(特别是基于聚丙烯酸酯和聚乙烯吡咯烷酮的成膜剂)。本发明的目的还在于开发一种化妆品制剂,其中可以省去使用合成聚合物,特别是基于聚丙烯酸酯的合成聚合物。
令人惊讶的是,该目的通过一种化妆品制剂得以实现,所述化妆品制剂含有
a)羟丙基甲基纤维素,和
b)黄原胶,
其中所述制剂不含聚丙烯酸酯、卡波姆和聚乙烯吡咯烷酮。
令人惊奇地,该目的还通过一种不含聚丙烯酸酯的化妆品制剂的粘度调节方法实现,其特征在于将羟丙基甲基纤维素和黄原胶的混合物添加到制剂中。
令人惊奇地,通过使用羟丙基甲基纤维素和黄原胶的混合物作为不含聚丙烯酸酯的化妆品制剂中的聚丙烯酸酯的替代物,也实现了该目的。
具有根据本发明的成分组合的制剂与其他纤维素和树胶相比具有更高的温度稳定性和储存稳定性。使用其他天然增稠剂如羟丙基淀粉磷酸酯、微晶纤维素或结冷胶在较长的储存期或升高的储存温度后观察到相分离(油分离),而本发明的物质组合表现得出人意料地稳定。
在本公开的范围内,“根据本发明”、“根据本发明有利的”等表述总是指根据本发明的制剂、根据本发明的用途和根据本发明的方法,除非个别情况另有说明。
根据本发明,可作为UV过滤剂的是在欧盟委员会的条例(EU)第866/2014号和条例第1223/2009号中在附件VI中列为UV过滤剂的所有物质。
根据本发明有利的是,使用平均分子量为80,000至90,000g/mol的化合物作为羟丙基甲基纤维素。根据本发明优选的是,羟丙基纤维素的2%水溶液在20℃具有400cPs的粘度。例如,根据本发明有利的是可以使用Dow Chemical公司的Methocel E4M Premium或来自SE Tylose GmbH&Co.KG的Tylose E707002。
根据本发明有利的是,可以使用在1%KCl溶液中在标准条件下在60rpm具有1200-1600mPa*s(cP)的粘度的化合物作为黄原胶。根据本发明有利的是,在标准条件下0.25%的自来水溶液在3rpm具有600-1200mPa*s(cP)的粘度。根据本发明有利的是,根据本发明的黄原胶在干燥状态下具有200目的粒度。根据本发明有利的是,例如可以使用来自CP Kelco公司的Keltrol CG-F V或来自Jungbunzlauer公司的食品级FF型和FFPC型黄原胶。
本发明的根据本发明有利的实施方案的特征在于,所述制剂包含一种或多种选自以下化合物组的UV过滤剂:4-(叔丁基)-4'-甲氧基二苯甲酰甲烷(INCI丁基甲氧基二苯甲酰甲烷)、(2-[-4-(二乙基氨基)-2-羟基苯甲酰基]苯甲酸己酯(INCI:二乙氨基羟苯甲酰基苯甲酸己酯)和2,4-双-{[4-(2-乙基己氧基)-2-羟基]-苯基}-6-(4-甲氧基苯基)-1,3,5-三嗪(INCI双乙基己氧基苯酚甲氧基苯基三嗪)。
如果制剂包含4-(叔丁基)-4'-甲氧基二苯甲酰甲烷(INCI丁基甲氧基二苯甲酰基甲烷),则根据本发明有利的使用浓度为1至5重量%,基于制剂的总重量。
如果制剂包含(2-[-4-(二乙基氨基)-2-羟基苯甲酰基]苯甲酸己酯(INCI:二乙氨基羟苯甲酰基苯甲酸己酯),则根据本发明有利的使用浓度为1至9重量%,基于制剂的总重量。
如果制剂包含2,4-双-{[4-(2-乙基己氧基)-2-羟基]-苯基}-6-(4-甲氧基苯基)-1,3,5-三嗪(INCI双乙基己氧基苯酚甲氧基苯基三嗪),则根据本发明有利的使用浓度为0.5至4.5重量%,基于制剂的总重量。
此外,根据本发明有利的实施方案的特征在于其含有一种或多种选自以下化合物组的UV过滤剂:2-苯基苯并咪唑-5-磺酸盐;亚苯基-1,4-双(2-苯并咪唑基)-3,3'-5,5'-四磺酸盐;1,4-二(2-氧代-10-磺基-3-亚冰片甲基)苯及其盐;4-(2-氧代-3-亚冰片甲基)苯磺酸盐;2-甲基-5-(2-氧代-3-亚冰片甲基)磺酸盐;2,2'-亚甲基-双(6-(2H-苯并三唑-2-基)-4-(1,1,3,3-四甲基丁基)苯酚);2-(2H-苯并三唑-2-基)-4-甲基-6-[2-甲基-3-[1,3,3,3-四甲基-1-[(三甲基甲硅烷基)氧基]二硅氧烷基]丙基]-苯酚;水杨酸乙基己酯;对苯二甲酸二樟脑磺酸盐;2-乙基己基-2-氰基-3,3-二苯基丙烯酸酯;4-(二甲基氨基)苯甲酸戊酯;4-甲氧基亚苄基丙二酸二(2-乙基己基)酯;4-甲氧基肉桂酸异戊酯;2-羟基-4-甲氧基-4'-甲基二苯甲酮;2,2'-二羟基-4-甲氧基二苯甲酮;水杨酸胡莫柳酯;2-乙基己基-2-羟基苯甲酸酯;聚二甲基硅氧烷二乙基亚苄基丙二酸酯;3-(4-(2,2-双乙氧基羰基乙烯基)-苯氧基)丙烯基)-甲氧基硅氧烷/二甲基硅氧烷-共聚物;二辛基丁基氨基三嗪酮(INCI:二乙基己基丁氨基三嗪酮);2,4-双-[5-1(二甲基丙基)苯并噁唑-2-基-(4-苯基)-亚氨基]-6-(2-乙基己基)-亚氨基-1,3,5-三嗪(CAS号288254-16-0);4,4',4"-(1,3,5-三嗪-2,4,6-三基三亚氨)-三苯甲酸三(2-乙基己酯)(也称为2,4,6-三-[苯胺基-(p-碳-2'-乙基-1'-己氧基)]-1,3,5-三嗪(INCI:乙基己基三嗪酮);2,4,6-三联苯基-4-基-1,3,5-三嗪;部花青;哌嗪衍生物;二氧化钛;氧化锌。
在此,特别地,根据本发明优选使用苯基苯并咪唑-5-磺酸盐、水杨酸乙基己酯、水杨酸胡莫柳酯、2-乙基己基-2-氰基-3,3-二苯基丙烯酸酯、二辛基丁基氨基三嗪酮(INCI:二乙基己基丁氨基三嗪酮)、4,4',4"-(1,3,5-三嗪-2,4,6-三基三亚氨)-三-苯甲酸三(2-乙基己基酯)(INCI:乙基己基三嗪酮)、二氧化钛。根据本发明特别优选的是UV过滤剂苯基苯并咪唑-5-磺酸盐、水杨酸乙基己酯、二辛基丁基氨基三嗪酮(INCI:二乙基己基丁氨基三嗪酮)、4,4',4"-(1,3,5-三嗪-2,4,6-三基三亚氨)-三-苯甲酸三(2-乙基己基酯)(INCI:乙基己基三嗪酮)。
苯基苯并咪唑-5-磺酸盐的根据本发明优选的使用浓度为0.5至4重量%,基于制剂的总重量,水杨酸乙基己酯的优选使用浓度为0.5至5重量%,基于总重量。
在本发明的意义上有利的是,制剂以1至30重量%的总浓度包含一种或多种UV过滤剂a),基于制剂的总重量。
根据本发明有利的是,制剂包含氢化菜籽油(INCI:氢化菜籽油)。这可以例如以商品名Dermofeel Viscolid pof从Evonik Nutrition&Care GmbH公司或Dr.StraetmansGmbH公司获得。
在此,根据本发明有利的是,制剂以0.5至3.0重量%的浓度包含氢化菜籽油(INCI:氢化菜籽油),基于制剂的总重量。
本发明的有利实施方案的特征还在于所述制剂不含3-(4-甲基亚苄基)樟脑、2-羟基-4-甲氧基二苯甲酮(INCI:氧苯酮)、4-甲氧基肉桂酸-2-乙基己酯(INCI甲氧基肉桂酸辛酯)、对羟基苯甲酸酯(特别是对羟基苯甲酸丙酯和丁酯)、甲基异噻唑啉酮、氯甲基异噻唑啉酮和DMDM乙内酰脲、聚乙二醇醚或聚乙二醇酯。
根据本发明有利的是,制剂含有浓度为0.05至0.5重量%的羟丙基甲基纤维素和浓度为0.1至1重量%的黄原胶,在每种情况下均基于制剂的总重量。
根据本发明优选的是,制剂含有浓度为0.1至0.5重量%的羟丙基甲基纤维素和浓度为0.3至0.7重量%的黄原胶,在每种情况下均基于制剂的总重量。
在本发明的意义上也有利的是,制剂中羟丙基甲基纤维素与黄原胶的重量比为1:2至2:7。
根据本发明有利的是,制剂是O/W乳液或水分散体的形式存在。
如果根据本发明的制剂为O/W乳液的形式,则其根据本发明有利的特征在于该制剂包含一种或多种选自以下化合物组的O/W乳化剂:硬脂酸柠檬酸甘油酯、硬脂酸甘油酯(自乳化)、硬脂酸、硬脂酸盐、聚甘油-3甲基葡萄糖二硬脂酸酯、鲸蜡硬脂基硫酸钠、鲸蜡基磷酸钾、聚甘油-10硬脂酸酯、硬脂酰谷氨酸钠。
根据本发明有利的是,制剂含有乙醇。根据本发明优选的是,以2至10重量%的浓度使用乙醇,基于制剂的总重量。
本发明意义上的有利实施方案的特征在于该制剂包含乙基己基甘油和/或4-羟基苯乙酮。
此外,根据本发明有利的是,制剂包含一种或多种选自以下化合物组的链烷二醇:1,2-戊二醇、1,2-己二醇、1,2-辛二醇、1,2-癸二醇、2-甲基-1,3-丙二醇。
本发明的根据本发明有利的实施方案的特征在于,所述制剂包含一种或多种选自以下化合物组的化合物:α-硫辛酸、叶酸、八氢番茄红素、D-生物素、辅酶Q10、α-葡糖基芦丁、肉碱、肌肽、天然和/或合成异黄酮、黄酮、肌酸、肌酐、牛磺酸、β-丙氨酸、泛醇、厚朴酚、和厚朴酚、醋酸生育酚、二羟基丙酮;8-十六碳烯-1,16-二羧酸、肽安密多、甘油基葡萄糖、(2-羟乙基)脲、维生素E或其衍生物、透明质酸和/或其盐和/或甘草查耳酮A。
根据本发明的制剂可以有利地包含保湿剂。赋予化妆品制剂如下特性的物质或物质混合物被称为保湿剂(润肤剂):在涂抹或分布在皮肤表面后减少角质层的水分释放(也称为经表皮失水(TEWL))和/或对角质层的水合产生积极影响。
本发明意义上的有利的保湿剂(润肤剂)例如是甘油、乳酸和/或乳酸盐,特别是乳酸钠,丁二醇、丙二醇、生物糖胶-1、野大豆提取物、乙基己氧基甘油、吡咯烷酮羧酸和尿素。此外,特别有利的是使用选自水溶性的和/或水中可溶胀的和/或借助水可凝胶化的多糖的聚合物润肤剂。特别有利的是例如透明质酸、壳聚糖和/或富含岩藻糖的多糖,其以注册号178463-23-5记载在《化学文摘》(Chemical Abstracts)中,并且例如可从SOLABIA S.A.公司以1000的名称获得。润肤剂也可以有利地用作抗皱成分以防止皮肤变化,例如在皮肤老化过程中发生的皮肤变化。
根据本发明的化妆品制剂也可以有利地(但不是必须地)包含填充剂,其例如进一步改善制剂的感官和美容特性,并且例如引起或增强天鹅绒般或丝滑的皮肤感觉。本发明意义上的有利填充剂是淀粉和淀粉衍生物(例如木薯淀粉、磷酸二淀粉、辛烯基琥珀酸铝淀粉或辛烯基琥珀酸钠淀粉等)、既不主要具有UV过滤剂效果也不具有着色效果的颜料(例如氮化硼等)和/或(CAS编号7631-86-9)和/或滑石粉。
根据本发明优选的是,根据本发明的制剂包含木薯淀粉和/或磷酸二淀粉。
本发明的根据本发明有利的实施方案的特征在于该制剂包含一种或多种选自以下化合物组的油:二辛酸/二癸酸丁二醇酯、苯甲酸苯乙酯、苯甲酸C12-15烷基酯、己二酸二丁酯;癸二酸二异丙酯、碳酸二辛酯、酒石酸二-C12-13烷基酯、水杨酸丁基辛酯、丁香亚基丙二酸二乙基己酯、氢化蓖麻油二聚酸酯、三庚酸甘油酯、乳酸C12-13烷基酯、苯甲酸C16-17烷基酯、辛酸丙基庚酯、辛酸/癸酸甘油三酯、2,6-萘二甲酸二乙基己酯、辛基十二醇、辛酸/癸酸甘油三酯、椰油酸乙基己酯。
在此,根据本发明优选的是,制剂含有己二酸二丁酯、碳酸二辛酯、二辛酸丁二醇酯/二癸酸丁二醇酯和/或苯甲酸C12-C15烷基酯。
根据本发明的制剂的水相可以有利地包含常规化妆品助剂,例如醇,特别是具有低碳数的醇,优选乙醇和/或异丙醇,或具有低碳数的多元醇,以及它们的醚,优选丙二醇、甘油、电解质、自晒黑剂等。
在本发明的意义上还有利的是,根据本发明的制剂包含一种或多种选自以下化合物组的香料:柠檬烯、柠檬醛、芳樟醇、α-异甲基紫罗兰酮、香叶醇、香茅醇、2-异丁基-4-羟基-4-甲基四氢吡喃、2-叔戊基环己基酯、3-甲基-5-苯基-1-戊醇、7-乙酰基-1,1,3,4,4,6-六甲基四氢化萘、己二酸二酯、α-戊基肉桂醛、α-甲基紫罗兰酮、戊基C丁基苯基甲基丙肉桂醛、水杨酸戊酯、戊基肉桂醇、茴香醇、安息香、苯甲醇、苯甲酸苄酯、肉桂酸苄酯、水杨酸苄酯、佛手柑油、苦橙油、丁基苯基甲基丙醛、豆蔻油、雪松醇、肉桂醛、肉桂醇、甲基巴豆酸香茅醇酯、柠檬油、香豆素、琥珀酸二乙酯、芳樟醇乙酯、丁香酚、树苔提取物、橡苔提取物、法尼醇、愈创木油、己基肉桂醛、水杨酸己酯、羟基香茅醛、薰衣草油、柠檬油、乙酸芳樟酯、柑橘油、薄荷醇PCA酯、甲基庚烯酮、肉豆蔻油、迷迭香油、甜橙油、松油醇、零陵香豆油、柠檬酸三乙酯和/或香草醛。
此外,根据本发明的制剂可以含有常规使用浓度的化妆品防晒剂常规成分。
具体实施方式
实施例
以下实施例旨在说明本发明而不对其进行限制。除非另有说明,所有的量、比例和百分比均基于制剂的重量和总量或总重量。
Claims (11)
1.一种化妆品制剂,其含有
a)羟丙基甲基纤维素,和
b)黄原胶,
其中所述制剂不含基于聚丙烯酸酯、卡波姆和聚乙烯吡咯烷酮的物质。
2.一种不含聚丙烯酸酯的化妆品制剂的粘度调节方法,其特征在于,向制剂添加羟丙基甲基纤维素和黄原胶的混合物。
3.羟丙基甲基纤维素和黄原胶的混合物在不含聚丙烯酸酯的化妆品制剂中作为聚丙烯酸酯的替代品的用途。
4.根据权利要求1所述的化妆品制剂、根据权利要求2所述的方法或根据权利要求3所述的用途,其特征在于,所述制剂包含一种或多种选自以下化合物组的UV过滤剂:4-(叔丁基)-4'-甲氧基二苯甲酰甲烷(INCI丁基甲氧基二苯甲酰基甲烷)、(2-[-4-(二乙氨基)-2-羟基苯甲酰基]苯甲酸己酯(INCI:二乙氨基羟苯甲酰基苯甲酸己酯)和2,4-双-{[4-(2-乙基己氧基)-2-羟基]-苯基}-6-(4-甲氧基苯基)-1,3,5-三嗪(INCI双乙基己氧基苯酚甲氧基苯基三嗪)。
5.根据前述权利要求中任一项所述的化妆品制剂、方法或用途,其特征在于,所述制剂包含氢化菜籽油(INCI:氢化菜籽油)。
6.根据前述权利要求中任一项所述的化妆品制剂、方法或用途,其特征在于,所述制剂不含3-(4-甲基亚苄基)-樟脑、2-羟基-4-甲氧基二苯甲酮(INCI:氧苯酮)、4-甲氧基肉桂酸-2-乙基己酯(INCI甲氧基肉桂酸辛酯)、对羟基苯甲酸酯(特别是对羟基苯甲酸丙酯和丁酯)、甲基异噻唑啉酮、氯甲基异噻唑啉酮和DMDM乙内酰脲、聚乙二醇醚或聚乙二醇酯。
7.根据前述权利要求中任一项所述的化妆品制剂、方法或用途,其特征在于,所述制剂含有浓度为0.05至0.5重量%的羟丙基甲基纤维素和浓度为0.1至1重量%的黄原胶,分别基于制剂的总重量。
8.根据前述权利要求中任一项所述的化妆品制剂、方法或用途,其特征在于,所述制剂中羟丙基甲基纤维素与黄原胶的重量比为1:2至2:7。
9.根据前述权利要求中任一项所述的化妆品制剂、方法或用途,其特征在于,所述制剂包含浓度为0.5至3重量%的氢化菜籽油(INCI:氢化菜籽油),基于制剂的总重量。
10.根据前述权利要求中任一项所述的化妆品制剂、方法或用途,其特征在于,所述制剂以O/W乳液或水分散体的形式存在。
11.根据前述权利要求中任一项所述的化妆品制剂、方法或用途,其特征在于,所述制剂以O/W乳液或水分散体的形式存在。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102020201799.9A DE102020201799A1 (de) | 2020-02-13 | 2020-02-13 | Polyacrylat-freie kosmetische Zubereitung |
DE102020201799.9 | 2020-02-13 | ||
PCT/EP2021/050661 WO2021160366A1 (de) | 2020-02-13 | 2021-01-14 | Polyacrylat-freie kosmetische zubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115052580A true CN115052580A (zh) | 2022-09-13 |
Family
ID=74236150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180012775.9A Pending CN115052580A (zh) | 2020-02-13 | 2021-01-14 | 不含聚丙烯酸酯的化妆品制剂 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20230083509A1 (zh) |
EP (1) | EP4103148A1 (zh) |
CN (1) | CN115052580A (zh) |
BR (1) | BR112022016035A2 (zh) |
DE (1) | DE102020201799A1 (zh) |
WO (1) | WO2021160366A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102021205683A1 (de) * | 2021-06-04 | 2022-12-08 | Beiersdorf Aktiengesellschaft | Wärmestabile, Polyacrylat-freie kosmetische Zubereitung |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103432017A (zh) * | 2006-05-11 | 2013-12-11 | 气体产品与化学公司 | 含有官能化聚合物的个人护理组合物 |
CN104185470A (zh) * | 2012-03-19 | 2014-12-03 | 宝洁公司 | 用于护肤组合物中的超吸收聚合物和硅氧烷弹性体 |
DE102017202838A1 (de) * | 2017-02-22 | 2018-08-23 | Beiersdorf Ag | Wasserfestes, sprühbares Sonnenschutzmittel |
US20190029942A1 (en) * | 2017-07-31 | 2019-01-31 | L'oreal | Salt activatable water resistant cosmetic composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19923648A1 (de) | 1999-05-22 | 2000-11-23 | Beiersdorf Ag | Kosmetische und dermatologische Hydrodispersion mit einem Gehalt an Bornitrid |
JP6328908B2 (ja) | 2012-11-14 | 2018-05-23 | 花王株式会社 | 水中油型乳化組成物 |
DE102013213170A1 (de) * | 2013-07-04 | 2015-01-08 | Beiersdorf Ag | Octocrylenfreies, geruchsstabiles Sonnenschutzmittel |
DE102017200723A1 (de) * | 2017-01-18 | 2018-07-19 | Beiersdorf Ag | Octocrylenfreies Sonnenschutzmittel mit Polyglyceryl-10 Stearat |
DE102018203498A1 (de) | 2018-03-08 | 2019-09-12 | Beiersdorf Ag | Sonnenschutzmittel mit reduzierter Textilverfleckung enthaltend hydriertes Pflanzenöl und eine UV-Filterkombination aus Ethylhexyl Triazone und 4-(tert.-Butyl)-4'-methoxydibenzoylmethan |
-
2020
- 2020-02-13 DE DE102020201799.9A patent/DE102020201799A1/de not_active Withdrawn
-
2021
- 2021-01-14 BR BR112022016035A patent/BR112022016035A2/pt unknown
- 2021-01-14 EP EP21701684.9A patent/EP4103148A1/de active Pending
- 2021-01-14 CN CN202180012775.9A patent/CN115052580A/zh active Pending
- 2021-01-14 WO PCT/EP2021/050661 patent/WO2021160366A1/de unknown
- 2021-01-14 US US17/904,039 patent/US20230083509A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103432017A (zh) * | 2006-05-11 | 2013-12-11 | 气体产品与化学公司 | 含有官能化聚合物的个人护理组合物 |
CN104185470A (zh) * | 2012-03-19 | 2014-12-03 | 宝洁公司 | 用于护肤组合物中的超吸收聚合物和硅氧烷弹性体 |
DE102017202838A1 (de) * | 2017-02-22 | 2018-08-23 | Beiersdorf Ag | Wasserfestes, sprühbares Sonnenschutzmittel |
US20190029942A1 (en) * | 2017-07-31 | 2019-01-31 | L'oreal | Salt activatable water resistant cosmetic composition |
Also Published As
Publication number | Publication date |
---|---|
BR112022016035A2 (pt) | 2022-10-18 |
WO2021160366A1 (de) | 2021-08-19 |
EP4103148A1 (de) | 2022-12-21 |
US20230083509A1 (en) | 2023-03-16 |
DE102020201799A1 (de) | 2021-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020200941B9 (en) | Octocrylene-free sunscreen composition with low stickiness | |
CN107028777B (zh) | 含有二氧化钛的防晒剂 | |
CN106983671B (zh) | 含二氧化钛的防晒剂 | |
CN103917218A (zh) | 含有包含由羟基-和醚-官能团构成的特定极性基团的部花青衍生物的化妆品和/或皮肤病学组合物 | |
WO2006034991A1 (de) | W/o-emulsion mit uv-lichtschutzfilterpigmenten | |
ES2815452T3 (es) | Uso de benzoato de dietilamino hidroxibenzoil hexilo en protectores solares cosméticos | |
EP1762217A1 (de) | UV-Filterkomposition enthaltend PPG-3 Benzylethermyristat | |
EP3863597A1 (de) | Sonnenschutzmittel mit einer kombination aus wachsen und cetylpalmitat | |
ES2785148T3 (es) | Producto protector solar que puede pulverizarse, resistente al agua | |
CN115052580A (zh) | 不含聚丙烯酸酯的化妆品制剂 | |
WO2021239478A1 (de) | Sonnenschutzmittel mit einer kombination aus wachsen, cetylpalmitat und hydriertem rapsöl | |
WO2018015095A1 (en) | Cosmetic composition containing hydrophobic flakes comprising fatty alcohols | |
BR102018005651A2 (pt) | protetor solar com triacontanila pvp | |
ES2901807T3 (es) | Producto protector solar con estearato de poliglicerilo-10 y citronelol | |
ES2901808T3 (es) | Producto protector solar con estearato de poliglicerilo-10 y linalool | |
WO2023194290A1 (en) | Improvement of the water resistance of cosmetic compositions comprising uv filters | |
WO2021239385A1 (de) | Sonnenschutzmittel mit einer kombination aus carnaubawachs und hydriertem rapsöl | |
WO2018015094A1 (en) | Cosmetic composition containing hydrophobic flakes | |
DE102011077082A1 (de) | Verwendung von Epsilon-Polylysin zur Verbesserung der Wasserfestigkeitkosmetischer oder dermatologischer Formulierungen | |
WO2019011669A1 (de) | Sonnenschutzmittel mit schutz durch textilverfleckung durch 4-(tert.-butyl)-4´-methoxydibenzoylmethan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |